Decision Aid Summary

Title Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer
Audience Women who are post-menopausal with hormone receptor-positive (ER+ and/or PR+) breast cancer considering adjuvant endocrine therapy after having surgery, radiation, and/or chemotherapy.
Options included Take tamoxifen.
Take an aromatase inhibitor.
Take tamoxifen first, then switch to an aromatase inhibitor.
Year of last update or review 2010
Format paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer American Society of Clinical Oncology (ASCO)
Where was it developed? www.asco.org/guidelines, guidelines@asco.org
American Society of Clinical Oncology
US
Health condition Breast Cancer
Type of decision aid Treatment
Language English
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
7 out of 7 criteria to be defined as a patient decision aid
6 out of 9 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2017-04-06.